Literature DB >> 17476002

Drug risks and free speech--can Congress ban consumer drug ads?

Miriam Shuchman.   

Abstract

Mesh:

Year:  2007        PMID: 17476002     DOI: 10.1056/NEJMp078080

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-10

2.  Direct to consumer advertising of drugs in Europe.

Authors:  Nicola Magrini; Maria Font
Journal:  BMJ       Date:  2007-09-15

3.  Direct-to-consumer information in Europe: the blurred margin between promotion and information.

Authors:  Giampaolo Velo; Ugo Moretti
Journal:  Br J Clin Pharmacol       Date:  2008-11       Impact factor: 4.335

4.  Reforming direct-to-consumer advertising.

Authors:  Bryan A Liang; Tim Mackey
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

5.  Direct to consumer advertising: the case for greater consumer control.

Authors:  Idris Guessous; Chiranjeev Dash
Journal:  J Gen Intern Med       Date:  2015-04       Impact factor: 5.128

6.  Direct-to-consumer television advertising: time to turn off the tube?

Authors:  Joseph S Ross; Richard L Kravitz
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

7.  Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?

Authors:  Charles S Wilcox; Leslie Franceschi; Adam Simmons
Journal:  Innov Clin Neurosci       Date:  2020-07-01

Review 8.  How numeracy influences risk comprehension and medical decision making.

Authors:  Valerie F Reyna; Wendy L Nelson; Paul K Han; Nathan F Dieckmann
Journal:  Psychol Bull       Date:  2009-11       Impact factor: 17.737

9.  Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

Authors:  Gregory A Abel; Harold J Burstein; Nathanael D Hevelone; Jane C Weeks
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

10.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.